Mark Goldstone Net Worth

What's Mark Goldstone's mailing address?

Mark's mailing address filed with the SEC is C/O GUARDION HEALTH SCIENCES, INC., 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON, TX, 77098.

Insiders trading at Guardion Health Sciences Inc

Over the last 6 years, insiders at Guardion Health Sciences Inc have traded over $1,626,803 worth of Guardion Health Sciences Inc stock and bought 131,721 units worth $845,035 . The most active insiders traders include Bradley Louis Radoff Family..., Andrew C Schmidt oraz Bret Scholtes. On average, Guardion Health Sciences Inc executives and independent directors trade stock every 273 days with the average trade being worth of $625,568. The most recent stock trade was executed by Bradley Louis Radoff Family... on 26 August 2024, trading 115,540 units of GHSI stock currently worth $1,626,803.

What does Guardion Health Sciences Inc do?

by applying the latest science, technology and research, guardion health sciences (ghs) has positioned itself to address the escalating demand for solutions that promise to improve life-diminishing health problems facing the aging baby boomer generation. guardion health sciences is dedicated to applying a scientific discipline and pharmaceutical approach to the development of safe, standardized and effective condition specific solutions. using the individual and collective knowledge of the members of our science advisory board, we will advise healthcare professionals and the public on the importance of medical foods and nutrition to achieve overall good health. the company’s first medical food, lumega-z, is scientifically formulated to restore and maintain the macular protective pigment. a depleted macular pigment is a known contributor to amd. though lumega-z was created with the amd epidemic in mind, its ingredients are also thought to be beneficial for other types of eye disease (i.

Guardion Health Sciences Inc executives and stock owners

Guardion Health Sciences Inc executives and other stock owners filed with the SEC include:

• Dr. David W. Evans MBA, Ph.D.,
  Chief Scientific Officer & Director
• Robert Neal Weingarten,
  Independent Chairman & Sec.
• Dr. David W. Evans,
  Chief Scientific Officer & Director
• Craig J. Sheehan,
  Chief Commercial Officer
• Jeffrey Benjamin,
  Chief Accounting Officer
• Andrew C. Schmidt,
  VP & CFO
• Bret D. Scholtes,
  Pres, CEO & Director
• Donald A Gagliano,
  Director
• Mark Goldstone,
  Director
• Robert N Weingarten,
  Director
• Bradley Louis Radoff Family...,
  
• Kelly Anderson,
  Director
• David W Evans,
  Chief Scientific Officer
• Michael Favish,
  Chief Executive Officer
• Craig Sheehan,
  Chief Commercial Officer
• Bret Scholtes,
  CEO and President
• Michaela Griggs,
  Director
• Janet Hall,
  CEO & President